Adeshwar Meditex Ltd

Adeshwar Meditex Ltd – Trading Window closed from October 01, 2026 for the unaudited financial results for the quarter and half year ending September 30, 2026; trading window will open 48 hours after the declaration of the said Financial Results.

AGM details

• AGM held physically on Sep 23, 2026 at 12:30 PM at registered office; remote e-voting available.

Resolutions

• All resolutions set out in the Notice were approved by members per Scrutinizer's Report.

Voting results

• Scrutinizer's report confirms all resolutions approved; no detailed vote counts provided.

AGM Details

• AGM held on Sep 23, 2026 at 12:30 PM IST at registered office (physical) with e-voting.
• Remote e-voting window ran Sep 20-22, 2026.
• Votes conducted; results to be announced after Scrutinizer's Report.

Resolutions & Voting

• Ordinary: Adoption of standalone financial statements and reports.
• Ordinary: Re-appointment of Abhinandan Nagaraja Rao as director by rotation.
• Ordinary: Appointment of Shankar Ramesh & Co. LLP as statutory auditors.
• Special: Appointment of Bhagyalaxmi Kavital as Non-Executive Independent Director for 5 years.

Director Changes

• Re-appointment of Abhinandan Nagaraja Rao as director by rotation.
• Appointment of Bhagyalaxmi Kavital as Independent Director for 5 years.

Auditor Appointments

• Appointment of Shankar Ramesh & Co. LLP as statutory auditors.

Book Closure Details

• Book closure from 17 Sep 2026 to 23 Sep 2026 (inclusive) for the 19th AGM.
• AGM date: 23 Sep 2026, 12:30 PM, at the registered office.
• Purpose: book closure for the 19th AGM.

AGM details

• AGM date/time: 23 September 2026 at 12:30 IST; venue: registered office; mode: physical.
• Record date for voting: 16 September 2026; share registers close 17–23 September 2026.

Ordinary resolutions

• Adoption of standalone financial statements for FY 2025-26 with Board and Auditor reports.
• Re-appointment of Nagaraja Rao Abhinandan as director liable to retire by rotation.
• Appointment of M/s Shankar Ramesh & Co. LLP as statutory auditors for five years.

Special resolution

• Appointment of Bhagyalaxmi Kavital as Non-Executive Independent Director for five years.

Voting and results

• Remote e-voting window: 9:00 AM to 5:00 PM, Sept 20–22, 2026.
• Cut-off date for voting: 16 September 2026.
• No results disclosed here; to be announced at AGM.
• E-voting provider: Bigshare i-Vote; Scrutinizer appointed.

Dividend

• Dividend not recommended for the year.

Director changes

• Arun Koli resigned as Independent Director on 28 April 2026.
• Prithvi Singh resigned as Non-Executive Director on 26 August 2026.
• Satish Chudekar resigned as Non-Executive Director on 3 August 2026.
• Raghupathy Bhat appointed as Additional Non-Executive Independent Director on 20 December 2025.
• Bhagyalaxmi Kavital appointed Additional Independent Director on 21 May 2026; to stand for AGM.
• Bhagyalaxmi Kavital to be appointed Independent Director for 5-year term at AGM.

Auditors

• Appointment of M/s Shankar Ramesh & Co. LLP as Statutory Auditors for five years.

Material related party transactions

• No material related party transactions disclosed; arm's length and ordinary course.

Other approvals

• Nomination and Remuneration Policy disclosed; Annexure II available on company site.

Financial highlights

• Revenue from operations: ₹5,610.38 lakhs in FY2025-26, down from ₹8,371.31.
• Total revenue: ₹5,620.76 lakhs; total expenses: ₹5,437.57.
• Net profit after tax: ₹126.49 lakhs.
• Earnings per share: ₹0.88 (basic and diluted).
• Tax: current ₹57.50 lakhs; deferred ₹0.80.
• Debt: short-term ₹434.67 lakhs; long-term ₹165.16.
• Dividend: no dividend declared for 2025-26.
• Cash and cash equivalents at year-end: ₹1.49 lakhs.

Operations & portfolio

• Diversified product portfolio includes sterile dressings, wound care, bandages, swabs.
• Export incentives recognised ₹3.61 lakhs.
• Exports momentum supported by policy and manufacturing strengths.
• MD&A notes rising wound care demand globally.

Capital & dividends

• Share capital: authorized ₹15 crore; issued ₹14.4314 crore.
• Promoter holdings: Abhinandan Rao 29.87%; Nagaraja Rao 27.80%.
• Dividend declared: none for the year.

Governance changes

• Independent director Udpa died Oct 22, 2025.
• Arun Koli (Independent) resigned Apr 28, 2026.
• Raghupathy Bhat appointed Additional Independent Director Dec 20, 2025; confirmed Jan 20, 2026.
• Bhagyalaxmi Kavital appointed Additional Independent Director May 21, 2026; term Sep 23, 2026–2031.
• Audit Committee met 6 times; chaired by Arun Shankar Koli.

Audits & compliance

• Statutory auditors: Shankar Ramesh & Co. LLP appointed for five years; pending AGM approval.
• Secretarial audit: Deep Shukla & Associates; two observations.

Management commentary & outlook

• MD&A highlights growth in global wound care market and Indian opportunity.
• Market drivers: healthcare expenditure, infrastructure, infection control.
• Outlook: focus on export opportunities and core competencies.

Regulatory & compliance

• Related party transactions: arm's length; no material conflicts.
• No subsidiaries or joint ventures.

Resignation details

• Resigning director: Mr. Prithvi Singh, Non-Executive Director.
• Directorship type: Non-Executive Director.
• Date of cessation: 26 August 2026.
• Reason for resignation: personal commitments.
• Confirmation: no other material reasons beyond those disclosed.
• Board/committee impact: Nomination & Remuneration Committee membership vacated.
• Other listed entity: Adeshwar Meditex Limited; Non-Executive Director; Nomination & Remuneration Committee Member.
• Regulatory or shareholder approval: Not stated in filing.
• Consequence on board/committee composition: Not disclosed.

Key board decisions

• Appointment of Ms. Bhagyalaxmi Kavital as Non-Executive Independent Director, subject to member approval.
• Resignation of Mr. Prithvi Singh as Non-Executive Director effective 26 August 2026.
• Director's Report for FY 2025-26 considered and approved.
• Resignation of M/s Basude Makote & Saini as Internal Auditors.
• Appointment of M/s Saini & Makote as Internal Auditors for FY 2026-27.
• Appointment of M/s Shankar Ramesh & Co. LLP as Statutory Auditors for 5 years, subject to shareholders' approval.
• Notice of 19th AGM on 23 September 2026 at 12:30 PM.
• Book closure from 17 to 23 September 2026 (inclusive).
• Appointed Mr. Deep Shukla as Scrutinizer for AGM e-voting.

Meeting Details

• Board meeting scheduled for Aug 26, 2026; time and venue not disclosed.

Key Agenda Items

• Appoint Ms. Bhagyalaxmi Kavital as Director (Non-Executive Independent) subject to members' approval
• Approve Director's Report for FY 2025-26 and annexures
• Consider and approve the notice for the 19th AGM
• Finalize Book Closure dates for the 19th AGM
• Finalize appointment of Scrutinizer for the voting process
• Any other matter with the permission of the Chair